Breast Cancer | Meet The Professor: Optimizing the Selection and Sequencing of Therapy for Patients with HER2-Positive Breast Cancer — Part 5

Featuring perspectives from Dr Hope Rugo, including the following topics: Introduction: DESTINY-Breast03 Trial (0:00) Case: A woman in her mid-60s with ER/PR-negative, HER2-positive metastatic breast cancer (mBC) — Raman Sood, MD (11:57) Case: A woman in her late 60s with ER/PR-negative, HER2-positive mBC — Rohit Gosain, MD (16:14) Case: A woman in her mid-50s with ER/PR-positive, HER2-positive mBC with brain metastases — Laila Agrawal, MD (22:59) Case: A woman in her early 30s with triple-positive mBC and possible mosaicism of TP53 mutation — Syed F Zafar, MD (30:06) Case: A woman in her late 30s with triple-positive, node-negative localized breast cancer — Namrata I Peswani, MD (45:43) Case: A woman in her early 60s with ER/PR-positive, HER2-positive, node-positive invasive ductal carcinoma — Shaachi Gupta, MD, MPH (49:32) Journal Club with Dr Rugo and SABCS® 2021 Preview (55:57) CME information and select publications